Opening Comments at the American Association for the Advancement of Science (AAAS) consultation on Human Enhancement
By Richard Hayes
| 06. 01. 2006
Mark Frankel asked if we’d share some general perspectives on what we believe to be the major challenges posed as we consider technologies of “enhancement.” I’d like to share the perspective of the Center for Genetics and Society, as well as what we’ve learned about the perspectives of a wide range of Americans and others.
CGS got started following a series of meetings held in 2000 on the social and political implications of the new human genetic technologies. The meetings brought together people concerned about social and economic justice, women’s health and reproductive rights, science and society, environmental protection, and the rights of the disabled.
Those participating became concerned when they learned how rapidly these new technologies were being developed, how profoundly consequential these could be, how thin were the few rules and regulations in place, and how well below the radar screens of both the general public and policy makers all this was.
A major concern was that use of these technologies could greatly exacerbate human inequality, in particular through a revival of eugenic technologies and ideologies, this time...
Related Articles
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...